Yulian Zhang, PhD
VP of Global BD
Triastek, Inc.
Former Executive Director of BD, Fosun Pharma US
Former BD head of Kelun Pharmaceutical, Boston
20+ years of experience in drug development and business development, having led the FDA approval of AYVAKYT® (avapritinib) and participated in the approval of GAVRETO® (pralsetinib)
Ph.D., Organic Chemistry, Temple University & MBA, Leonard N. Stern School of Business, New York University
Speaking In
-
03-Jun-2024Triastek, Inc.Company Presentation Theater 4
)
)
)
)
)
)
){kind=logo}
){kind=logo}
.png/fit-in/500x500/filters:no_upscale())